Cargando…
COVID‐19 pneumonia in a patient with sarcoidosis: A case report
Key prognostic elements to consider in sarcoidosis patients who contract COVID‐19 pneumonia are pulmonary involvement, the underlying immune system dysfunction, immunosuppressive therapies’ use, and the increased risk for hypercoagulability.
Autores principales: | Ramdani, Hanae, Benelhosni, Khadija, Moatassim Billah, Nabil, Nassar, Ittimade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869356/ https://www.ncbi.nlm.nih.gov/pubmed/33598270 http://dx.doi.org/10.1002/ccr3.3684 |
Ejemplares similares
-
Chest CT in covid-19 pneumonia's follow-up: A 30 patients case series
por: Ramdani, Hanae, et al.
Publicado: (2022) -
Spontaneous pneumomediastinum as an unusual complication of COVID‐19 pneumonia
por: Ramdani, Hanae, et al.
Publicado: (2021) -
Retromandibular vein ectasia : A parotid mass mimicker
por: Ramdani, Hanae, et al.
Publicado: (2021) -
An unusual cause of pulmonary hypertension: Mediastinal hydatid cyst
por: Ramdani, Hanae, et al.
Publicado: (2021) -
Infected Urachal Sinus in an Adult
por: Ramdani, Hanae, et al.
Publicado: (2021)